The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis

Abstract Background The performance of the galactomannan enzyme immunoassay (GM-EIA) is impaired in patients receiving mould-active antifungal therapy. The impact of mould-active antifungal therapy on Aspergillus PCR testing needs to be determined. Objectives To determine the influence of anti-mould...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of antimicrobial chemotherapy 2021-02, Vol.76 (3), p.635-638
Hauptverfasser:	Cruciani, M, White, P L, Mengoli, C, Löffler, J, Morton, C O, Klingspor, L, Buchheidt, D, Maertens, J, Heinz, W J, Rogers, T R, Weinbergerova, B, Warris, A, Lockhart, D E A, Jones, B, Cordonnier, C, Donnelly, J P, Barnes, R A
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspergillosis - diagnosis Aspergillosis - prevention & control Aspergillus - genetics Humans Invasive Fungal Infections Mannans Meta-Analysis as Topic Polymerase Chain Reaction Sensitivity and Specificity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!